Granules India Limited (NSE: GRANULES)
India
· Delayed Price · Currency is INR
596.85
+10.15 (1.73%)
Dec 24, 2024, 3:30 PM IST
Granules India Company Description
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.
The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors.
It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.
Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Granules India Limited
Country | India |
Founded | 1984 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 4,057 |
Contact Details
Address: My Home Hub Hyderabad, 500081 India | |
Phone | 91 40 6904 3500 |
Website | granulesindia.com |
Stock Details
Ticker Symbol | GRANULES |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE101D01020 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. | Joint MD, Chief Executive Officer and Additional Director |
Dr. Krishna Prasad Chigurupati B.Sc. | Chairman and MD |
Harsha Chigurupati BBA | Executive Director |
Sanjay Kumar | President and Chief Strategy and Sustainability Officer |
Mukesh Surana | Chief Financial Officer |
Sethu Madhavan Sankaran | Senior Vice President of API Manufacturing and Operations |
Dr. P. V. Srinivas | Chief Technology Officer |
Chaitanya Tummala | Company Secretary and Compliance Officer |
Atul Dhavle B.E. | Chief Human Resources Officer |
Priyanka Chigurupati | Whole-Time Director |